Hospitals Are an Opportunity to Close the Osteoporosis Treatment Gap
Authors:
Open Access
- 5 October 2026
- journal article
- editorial
- Published by Springer Nature in Journal of General Internal Medicine
- p. 1-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Underprescribing of Antifracture Medications Following Non-Traumatic Fracture: A Retrospective Cohort StudyJournal of General Internal Medicine, 2026
- Antiosteoporosis Medication Prescriptions After Fragility FracturesJAMA Network Open, 2024
- Zoledronic acid for hip fracture during initial hospitalizationJournal of Bone and Mineral Research, 2024
- Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysisOsteoporosis International, 2024
- Lessons Learned: Evaluation of Fracture Liaison Service Quality Improvement Efforts in a Large Academic Healthcare SystemJournal of General Internal Medicine, 2023
- Osteoporosis Medications Prevent Subsequent Fracture in Frail Older AdultsJournal of Bone and Mineral Research, 2020
- Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder CoalitionJournal of Bone and Mineral Research, 2019
- Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral FracturesJAMA Network Open, 2018
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Mortality, Disability, and Nursing Home Use for Persons with and without Hip Fracture: A Population‐Based StudyJournal of the American Geriatrics Society, 2002